Second External Quality Assurance Study for the Serological Diagnosis of Hantaviruses in Europe
Open Access
- 3 April 2012
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS Neglected Tropical Diseases
- Vol. 6 (4) , e1607
Abstract
Hantaviruses are endemic throughout the world and hosted by rodents and insectivores. Two human zoonoses, hemorrhagic fever with renal syndrome (HFRS) and hantavirus pulmonary syndrome (HPS), are caused by hantaviruses and case fatality rates have reached 12% for HFRS and 50% for HPS in some outbreaks. Symptomatic hantavirus infections in Europe are summarised as HFRS mainly due to Puumala, Dobrava-Belgrade and Saaremaa virus. While HFRS has an overall low incidence in Europe, the number of cases varies from 100 per year in all Eastern and Southern Europe up to 1,000 per year only in Finland. To assess the quality of hantavirus diagnostics, the European Network for the Diagnostics of “Imported” Viral Diseases (ENIVD) organised a first external quality assurance (EQA) in 2002. The purpose of this second EQA study is to collect updated information on the efficiency and accurateness of hantavirus serological methods applied by expert laboratories. A serum panel of 14 samples was sent to 28 participants in Europe of which 27 sent results. Performance in hantavirus diagnosis varied not only on the method used but also on the laboratories and the subclass of antibodies tested. Commercial and in-house assays performed almost equally. Enzyme immunoassays were mainly used but did not show the best performances while immunoblot assays were the less employed and showed overall better performances. IgM antibodies were not detected in 61% of the positive IgM samples and IgM detection was not performed by 7% of the laboratories indicating a risk of overlooking acute infections in patients. Uneven performances using the same method is indicating that there is still a need for improving testing conditions and standardizing protocols. Hantaviruses are endemic throughout the world and naturally hosted by rodents. The vast majority of human hantavirus infections are asymptomatic. In Europe, symptomatic hantavirus infections are summarised as hemorrhagic fever with renal syndrome (HFRS) mainly due to Puumala, Dobrava-Belgrade and Saaremaa virus. HFRS can cause fever, headache, and flank and abdominal pain. Moreover, renal dysfunction can lead to acute renal failure. Despite numerous research efforts, there is still no safe and effective vaccine or specific antiviral treatment against hantavirus infections. In this context, an accurate diagnosis as well as a reliable surveillance of hantavirus infections is essential. The diagnostics of hantavirus infections are based on serology using in-house or commercial assays. To assess the quality of hantavirus diagnostics, the European Network for the Diagnostics of “Imported” Viral Diseases organised a first external quality assurance (EQA) in 2002. In this publication we describe a second EQA study launched in 2011 with the objective to collect updated information on the efficiency and accurateness of hantavirus serological methods applied by expert laboratories. The study shows uneven performances indicating that there is still a need for improving testing conditions and standardizing protocols.Keywords
This publication has 14 references indexed in Scilit:
- 2nd International External Quality Control Assessment for the Molecular Diagnosis of Dengue InfectionsPLOS Neglected Tropical Diseases, 2010
- International diagnostic accuracy study for the serological detection of chikungunya virus infectionClinical Microbiology and Infection, 2009
- Hantavirus infections in Europe: from virus carriers to a major public-health problemExpert Review of Anti-infective Therapy, 2009
- Situation of hantavirus infections and haemorrhagic fever with renal syndrome in European countries as of December 2006Eurosurveillance, 2008
- First international diagnostic accuracy study for the serological detection of West Nile virus infectionBMC Infectious Diseases, 2007
- Development of Novel Immunoglobulin G (IgG), IgA, and IgM Enzyme Immunoassays Based on Recombinant Puumala and Dobrava Hantavirus Nucleocapsid ProteinsClinical and Vaccine Immunology, 2006
- Central European Dobrava Hantavirus Isolate from a Striped Field Mouse ( Apodemus agrarius )Journal of Clinical Microbiology, 2005
- Hantaviruses: Immunology, Treatment, and PreventionViral Immunology, 2004
- Quality control measures for the serological diagnosis of hantavirus infectionsJournal of Clinical Virology, 2003
- infections and their preventionMicrobes and Infection, 2001